跳至主要内容
临床试验/CTRI/2022/03/040919
CTRI/2022/03/040919尚未招募不适用

A clinical study to evaluate the efficacy of sadabhadradyam churna and vrehddhatrayaadi kwath in the management of benign prostratic hyperplasia(BPH).

MMM GovtAyurved CollegeUdaipurRajasthan1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2022年3月15日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
Improvement in signs and symptoms of benign prostatic hyperplasia.

研究概览

简要总结

This is a interventional multiple arm clinical trial  to evaluate the efficacy of sadabhadradyam churna and vrehddhatrayadi kwath in the management of benign prostatic hyperplasia.First Group is given   sadabhadradyam churna ,second group is given  vrehddhatrayadi kwath and third group is given both the medicines.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Not Applicable

入排标准

年龄范围
40.00 Year(s) 至 75.00 Year(s)(—)
性别
Male

入选标准

  • Signs and symptoms of benign prostate hyperplasia 2)Residual urine <120 ml.

排除标准

  • Residual urine >120 ml 2)Prostatic carcinoma 3)Complete urine retention.

结局指标

主要结局

Improvement in signs and symptoms of benign prostatic hyperplasia.

时间窗: 2 months.

次要结局

  • Improvement in signs and synptoms of benign prostatic hyperplasia.(15 days,30 days and 45 days.)

研究者

发起方
MMM GovtAyurved CollegeUdaipurRajasthan
申办方类型
Government medical college

研究点 (1)

Loading locations...

相似试验